Latest News


Each news article below shows only part of the news story. To view the full story, click on Read More below the story. 

  • February 11, 2019 11:12 AM | Anonymous

    February 11, 2019, Endorcine Today 

    The risk for developing a "more aggressive" form of breast cancer is higher among women with type 2 diabetes compared with women without diabetes, according to findings published in Diabetes Care. Use of insulin analogues did not increase risk for more aggressive breast cancers, according to researchers. 

    Read more.

  • February 11, 2019 11:04 AM | Anonymous

    February 11, 2019, Medscape

    Robotic mastectomy for invasive breast cancer was performed for the first time in the United States last year, but the move toward this surgical approach ground to a halt soon afterward. The first such operation was performed in September 2018 by Stephen Chagares, MD, at the Monmouth County Medical Center in Long Branch, New Jersey.

    Read more.




  • February 11, 2019 10:32 AM | Anonymous

    February 11, 2019, Aleece Fosnight, APAOG President 
    via National Coalition for Sexual Health and Healthy Teen Network  

    The National Coalition for Sexual Health is sharing HPV resources from Healthy Teen Network related to HPV education in the form of a short video, "HPV: Not Too Late."

    From Healthy Teen Network : "Want to spread the word that it’s not too late for young adults to get the HPV vaccine? We’ve prepared this social media kit to make it easy to share our short video, HPV: Not Too Late."  

    APAOG will be sharing posts on our social media page throughout the remainder of February and encourage you to do the same!

    Click here to view the information on the Healthy Teen Network website, including suggested social media posts, hashtags and graphics! These resources are fantastic ways to integrate into your practice regarding HPV education.  


  • February 07, 2019 3:02 PM | Anonymous

    February 7, 2019, MedPage Today 

    A biosimilar to trastuzumab (Herceptin) demonstrated noninferiority versus the branded drug in a randomized trial of patients with metastatic HER2-positive breast cancer.

    Treatment with Pfizer's biosimilar PF-05280014 plus paclitaxel led to objective responses in 62.5% of patients with metastatic HER2-positive breast cancer compared with 66.5% for European-sourced (EU) trastuzumab and the taxane, a difference that met statistical requirements for noninferiority. The two treatment groups had virtually identical progression-free survival (PFS), as reported in the British Journal of Cancer(BJC).

    Read more.
  • February 07, 2019 3:00 PM | Anonymous

    February 7, 2019, Endocrine Today 

    Pregnant women who incorporate more vitamin C into their diets are at lower risk for developing gestational diabetes than those with insufficient or even adequate dietary vitamin C intake, according to findings published in Clinical Nutrition. 

    Read more.

  • February 07, 2019 2:57 PM | Anonymous

    February 7, 2019, University of Helsinki via ScienceDaily 

    Researchers in Finland have discovered a drug combination that collaborates with the cancer cells' own MYC oncoprotein, which in large quantities causes self-destruction of the cancer cells. When this combination is enhanced with immune system-boosting anti-PD-1 therapy, a more effective and long-lasting therapeutic effect can be seen in mice. These findings pave the way for new treatment combination strategies to harness the body's natural defenses to fight cancer.  

    Read more.

  • February 04, 2019 9:11 AM | Anonymous

    February 4, 2019, MedPage Today  

    A relatively fast outpatient procedure helped infertile women become pregnant — without the need for pills or in vitro fertilization, researchers said here. Using micro-catheters and a 0.018-inch guide-wire, physicians can perform proximal fallopian tube recanalization in less than the time it takes to watch a feature length movie, reported Jeff Wang, BS, a fourth-year medical student at Chicago Medical School. 

    Read more.

  • January 31, 2019 1:19 PM | Anonymous

    January 31, 2019, MedPage Today 

    Higher levels of stromal tumor infiltrating lymphocytes (sTILs) at diagnosis of early triple-negative breast cancer (TNBC) had a significant association with improved disease-free survival (DFS) and overall survival, data for more than 2,000 patients showed. Each 10 percent increment in baseline sTILs correlated with a 13 percent reduction in the hazard ratio for invasive disease-free survival (iDFS), a 17 percent reduction in hazard for distant (d)DFS, and a 16 percent reduction in the hazard for overall survival (OS).  

    Read more.

  • January 30, 2019 8:35 AM | Anonymous

    January 30, 2019, MedPage Today  

    Breast cancer patients showed increased long-term risk of atrial fibrillation (AF), with a short-term risk for younger women as well, a population-based Danish study indicated. Women younger than age 60 were more than twice as likely to have AF during the first six months after cancer diagnosis, and risk was increased by 80 percent from six months to three years, according to Maria D'Souza, MD, of Copenhagen University Hospital Herlev-Gentofte in Hellerup, Denmark, and colleagues. 

    Read more.

  • January 30, 2019 8:32 AM | Anonymous

    January 30, 2019, HemOnc Today  

    Rates of HPV-positive tumors are increasing among patients with oropharyngeal cancer in the U.S., regardless of sex or race, according to a retrospective cohort study published in Cancer. Additionally, gender and race are independently associated with survival in HPV-negative — but not HPV-positive — tumor status, researchers observed. 

    Read more. 


Powered by Wild Apricot Membership Software